Other Deals - Listed Firms
Mylan launches block deal to sell stake in Biocon for up to $363-M
Mylan, a unit of Viatris, has launched a block deal to sell a minority stake in Bengaluru-based, publicly listed biotech firm Biocon for up to USD 363 million (INR 3,481 crore). The firm plans to offload 92 million shares, representing 5.64% of the company's equity, at a floor price of INR 378.50 per share. Jefferies and Citi are acting as the joint bookrunners for the transaction.The stake sale follows a series of corporate restructuring activities, including Biocon’s acquisition of Viatris’s holding in Biocon Biologics earlier this year to simplify the parent company’s balance sheet and focus on deleveraging.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
